Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00346333 · ClinicalTrials.gov registry record · Phase 3
Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A
A Phase 3 study, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- Phase 3
- Development phase
- 240
- Enrollment target
NCT00346333 is a Phase 3 study that has completed, run by National Eye Institute (NEI). The registered enrollment target is 240 participants.
The verdict
NCT00346333, a Phase 3 study, has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 240 participants
- Enrollment target
Study Summary
The purpose of this trial is to determine whether lutein in addition to vitamin A will slow the course of retinitis pigmentosa.
Interventions
- DRUG Lutein
- DIETARY_SUPPLEMENT Cornstarch control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2003-07 |
| Est. Completion | 2008-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00346333
The ClinicalTrials.gov registry entry for NCT00346333 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lutein is the first listed.
NCT00346333 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00346333 about?
NCT00346333 is a clinical study titled "Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A". The purpose of this trial is to determine whether lutein in addition to vitamin A will slow the course of retinitis pigmentosa.
What is the current status of trial NCT00346333?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 240 participants. The study started on 2003-07. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00346333?
The interventions under investigation include: Lutein (DRUG), Cornstarch control (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00346333?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.